{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:00:45Z","timestamp":1772262045012,"version":"3.50.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:p>As there are currently no absolute immunohistochemical positive markers for the definite diagnosis of malignant epithelioid mesothelioma, the identification of additional \u201cpositive\u201d markers that may facilitate this diagnosis becomes of clinical importance. Therefore, the aim of this study was to identify novel positive markers of malignant mesothelioma. Whole genome gene expression analysis was performed using RNA extracted from formalin-fixed paraffin-embedded tissue sections of epithelioid mesothelioma and pulmonary adenocarcinoma. Gene expression analysis revealed that disabled homolog 2 (DAB2) and Intelectin-1 had significantly higher expression in epithelioid mesothelioma compared with that in pulmonary adenocarcinoma. The increased mRNA expression of DAB2 and Intelectin-1 was validated by reverse transcriptase polymerase chain reaction of RNA from tumor tissue and protein expression was validated by Western blotting of 5 mesothelioma cell lines. The utility of DAB2 and Intelectin-1 in the differential diagnosis of epithelioid mesothelioma and pulmonary adenocarcinoma was examined by an immunohistochemical study of 75 cases of epithelioid mesothelioma and 67 cases of pulmonary adenocarcinoma. The positive rates of DAB2 and Intelectin-1 expression in epithelioid mesothelioma were 80.0% and 76.0%, respectively, and 3.0% and 0%, respectively, in pulmonary adenocarcinoma. Immunohistochemically, the sensitivity and specificity of DAB2 was 80% and 97% and those of Intelectin-1 were 76% and 100% for differentiation of epithelioid mesothelioma from pulmonary adenocarcinoma. In conclusion, DAB2 and Intelectin-1 are newly identified positive markers of mesothelioma and have potential to be included in future immunohistochemical marker panels for differentiation of epithelioid mesothelioma from pulmonary adenocarcinoma.<\/jats:p>","DOI":"10.1097\/pas.0000000000000852","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T06:53:55Z","timestamp":1491634435000},"page":"1045-1052","source":"Crossref","is-referenced-by-count":21,"title":["Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for Its Differentiation From Pulmonary Adenocarcinoma"],"prefix":"10.1097","volume":"41","author":[{"given":"Masatsugu","family":"Kuraoka","sequence":"first","affiliation":[{"name":"Pathology"},{"name":"Surgery, Institute of Biomedical and Health Sciences"},{"name":"Department of Clinical Research and Laboratory, Hiroshima Prefectural Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishwa J.","family":"Amatya","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kushitani","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany S.","family":"Mawas","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Department of Pathology and Clinical Pathology, South Valley University, Qena, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Okayama Rosai Hospital, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouki","family":"Inai","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Pathologic Diagnostic Center Inc., Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nishisaka","sequence":"additional","affiliation":[{"name":"Department of Clinical Research and Laboratory, Hiroshima Prefectural Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taijiro","family":"Sueda","sequence":"additional","affiliation":[{"name":"Surgery, Institute of Biomedical and Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Takeshima","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2471\/BLT.11.086678","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Delgermaa","year":"2011","journal-title":"Bull World Health Organ"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"R8-20230922","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.2016.181","article-title":"MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma","author":"Amatya","year":"2017","journal-title":"Mod Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/sj.onc.1201769","article-title":"DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer","volume":"16","author":"Mok","year":"1998","journal-title":"Oncogene"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/1759-7714.12242","article-title":"Micro ribonucleic acid-93 promotes proliferation and migration of esophageal squamous cell carcinoma by targeting disabled 2","volume":"6","author":"Li","year":"2015","journal-title":"Thorac Cancer"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1038\/onc.2013.381","article-title":"miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer","volume":"33","author":"Du","year":"2014","journal-title":"Oncogene"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"9906","DOI":"10.1158\/0008-5472.CAN-05-1481","article-title":"The role of DOC-2\/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer","volume":"65","author":"Zhoul","year":"2005","journal-title":"Cancer Res"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-006-9422-6","article-title":"Frequent loss of DAB2 protein and infrequent promoter hypermethylation in breast cancer","volume":"104","author":"Bagadi","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/onc.2011.269","article-title":"Regulation of ovarian cancer progression by microRNA-187 through targeting disabled homolog-2","volume":"31","author":"Chao","year":"2012","journal-title":"Oncogene"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/MAJ.0000000000000436","article-title":"Aberrant hypermethylation at sites 86 to 226 of DAB2 gene in non-small cell lung cancer","volume":"349","author":"Li","year":"2015","journal-title":"Am J Med Sci"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"23456","DOI":"10.1074\/jbc.M103162200","article-title":"Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall","volume":"276","author":"Tsuji","year":"2001","journal-title":"J Biol Chem"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"e39889","DOI":"10.1371\/journal.pone.0039889","article-title":"Specific expression of human intelectin-1 in malignant pleural mesothelioma and gastrointestinal goblet cells","volume":"7","author":"Washimi","year":"2012","journal-title":"PLoS One"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/sj.bjc.6605786","article-title":"Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion","volume":"103","author":"Tsuji","year":"2010","journal-title":"Br J Cancer"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00432-011-1088-8","article-title":"Aberrant expression of intelectin-1 in gastric cancer: its relationship with clinicopathological features and prognosis","volume":"138","author":"Zheng","year":"2012","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201708000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:38:32Z","timestamp":1695422312000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201708000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000852","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}